Kostas Zervas

938 total citations
14 papers, 669 citations indexed

About

Kostas Zervas is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Kostas Zervas has authored 14 papers receiving a total of 669 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 9 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Kostas Zervas's work include Multiple Myeloma Research and Treatments (10 papers), Bone health and treatments (4 papers) and Peptidase Inhibition and Analysis (4 papers). Kostas Zervas is often cited by papers focused on Multiple Myeloma Research and Treatments (10 papers), Bone health and treatments (4 papers) and Peptidase Inhibition and Analysis (4 papers). Kostas Zervas collaborates with scholars based in Greece, France and United Kingdom. Kostas Zervas's co-authors include Evgenia Verrou, Evangelos Terpos, Eirini Katodritou, Dimitra Mihou, Anastasia Banti, Meletios Α. Dimopoulos, Konstantinos Vahtsevanos, Deborah J. Heath, Peter I. Croucher and Anastasia Pouli and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Haematology.

In The Last Decade

Kostas Zervas

14 papers receiving 650 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Kostas Zervas 512 353 225 148 78 14 669
Konstantinos Tsionos 434 0.8× 317 0.9× 189 0.8× 207 1.4× 66 0.8× 22 630
Evangelos Eleftherakis-Papaiakovou 433 0.8× 231 0.7× 209 0.9× 152 1.0× 43 0.6× 10 549
Francesco Pietrogrande 174 0.3× 88 0.2× 141 0.6× 22 0.1× 65 0.8× 21 352
Kyoko Haraguchi 99 0.2× 132 0.4× 92 0.4× 69 0.5× 36 0.5× 27 457
Edgardo Angtuaco 300 0.6× 440 1.2× 37 0.2× 246 1.7× 82 1.1× 14 645
Aref Chehal 118 0.2× 133 0.4× 68 0.3× 22 0.1× 136 1.7× 21 328
Maximilian Merz 216 0.4× 369 1.0× 26 0.1× 189 1.3× 59 0.8× 38 451
Ioannis Melakopoulos 1.4k 2.8× 153 0.4× 1.0k 4.6× 87 0.6× 15 0.2× 21 1.5k
Sabine Bréchignac 72 0.1× 367 1.0× 27 0.1× 78 0.5× 274 3.5× 32 526
Vassiliki Koutsoukou 879 1.7× 54 0.2× 623 2.8× 64 0.4× 9 0.1× 8 972

Countries citing papers authored by Kostas Zervas

Since Specialization
Citations

This map shows the geographic impact of Kostas Zervas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kostas Zervas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kostas Zervas more than expected).

Fields of papers citing papers by Kostas Zervas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kostas Zervas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kostas Zervas. The network helps show where Kostas Zervas may publish in the future.

Co-authorship network of co-authors of Kostas Zervas

This figure shows the co-authorship network connecting the top 25 collaborators of Kostas Zervas. A scholar is included among the top collaborators of Kostas Zervas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kostas Zervas. Kostas Zervas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Katodritou, Eirini, Evangelos Terpos, Charikleia Kelaïdi, et al.. (2013). Treatment with bortezomib‐based regimens improves overall response and predicts for survival in patients with primary or secondary plasma cell leukemia: Analysis of the Greek myeloma study group. American Journal of Hematology. 89(2). 145–150. 43 indexed citations
2.
3.
Badros, Ashraf, Evangelos Terpos, Eirini Katodritou, et al.. (2008). Natural History of Osteonecrosis of the Jaw in Patients With Multiple Myeloma. Journal of Clinical Oncology. 26(36). 5904–5909. 114 indexed citations
4.
Zervas, Kostas, et al.. (2007). Pulmonary Hypertension after Thalidomide Administration in Multiple Myeloma Patients. Pilot Study.. Blood. 110(11). 4846–4846. 1 indexed citations
5.
Petropoulou, Anna D., et al.. (2007). Kinetics of Thrombin Generation in Patients with Multiple Myeloma.. Blood. 110(11). 3535–3535. 1 indexed citations
6.
Mihou, Dimitra, Eirini Katodritou, & Kostas Zervas. (2007). Multiple myeloma staging based on the combination of beta-2-microglobulin and albumin: The role of albumin in the model. Hematology. 12(6). 527–531. 13 indexed citations
7.
Katodritou, Eirini, Matthaios Speletas, Kostas Zervas, et al.. (2006). Evaluation of Hypochromic Erythrocytes in Combination with sT fR-F Index for Predicting Response to r-HuEPO in Anemic Patients with Multiple Myeloma. PubMed. 12(1). 47–54. 11 indexed citations
8.
Terpos, Evangelos, et al.. (2006). Bortezomib is an effective agent for MDS/MPD syndrome with 5q− anomaly and thrombocytosis. Leukemia Research. 31(4). 559–562. 23 indexed citations
9.
Zervas, Kostas, Evgenia Verrou, Konstantinos Vahtsevanos, et al.. (2006). Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: a single‐centre experience in 303 patients. British Journal of Haematology. 134(6). 620–623. 212 indexed citations
10.
Terpos, Evangelos, Deborah J. Heath, Amin Rahemtulla, et al.. (2006). Bortezomib reduces serum dickkopf‐1 and receptor activator of nuclear factor‐κB ligand concentrations and normalises indices of bone remodelling in patients with relapsed multiple myeloma. British Journal of Haematology. 135(5). 688–692. 170 indexed citations
11.
Terpos, Evangelos, Deborah J. Heath, Amin Rahemtulla, et al.. (2006). Bortezomib Reduces Serum Dickkopf-1 and RANKL Concentrations and Normalizes Indices of Bone Remodeling in Patients with Relapsed Multiple Myeloma.. Blood. 108(11). 506–506. 3 indexed citations
12.
13.
Gerotziafas, Grigoris, et al.. (2003). Inhibition of factor VIIa generation and prothrombin activation by treatment with enoxaparin in patients with unstable angina*. British Journal of Haematology. 120(4). 611–617. 17 indexed citations
14.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Konstantinos Tsionos Breakdown of academic impact, for papers by Evangelos Eleftherakis-Papaiakovou Breakdown of academic impact, for papers by Francesco Pietrogrande Breakdown of academic impact, for papers by Kyoko Haraguchi Breakdown of academic impact, for papers by Edgardo Angtuaco Breakdown of academic impact, for papers by Aref Chehal Breakdown of academic impact, for papers by Maximilian Merz Breakdown of academic impact, for papers by Ioannis Melakopoulos Breakdown of academic impact, for papers by Sabine Bréchignac Breakdown of academic impact, for papers by Vassiliki Koutsoukou
Rankless by CCL
2026